DE859635T1 - Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine - Google Patents

Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine

Info

Publication number
DE859635T1
DE859635T1 DE0859635T DE96934972T DE859635T1 DE 859635 T1 DE859635 T1 DE 859635T1 DE 0859635 T DE0859635 T DE 0859635T DE 96934972 T DE96934972 T DE 96934972T DE 859635 T1 DE859635 T1 DE 859635T1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
compositions containing
stabilized pharmaceutical
dobutamine
containing dobutamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0859635T
Other languages
English (en)
Inventor
Daniele Kalifa-Madar
Francois Dietlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9483984&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE859635(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of DE859635T1 publication Critical patent/DE859635T1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE0859635T 1995-10-27 1996-10-25 Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine Pending DE859635T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9512688A FR2740337B1 (fr) 1995-10-27 1995-10-27 Compositions pharmaceutiques stabilisees contenant un derive ayant une activite adrenergique
PCT/FR1996/001671 WO1997015329A1 (fr) 1995-10-27 1996-10-25 Compositions pharmaceutiques stabilisees contenant de la dobutamine

Publications (1)

Publication Number Publication Date
DE859635T1 true DE859635T1 (de) 1999-01-07

Family

ID=9483984

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0859635T Pending DE859635T1 (de) 1995-10-27 1996-10-25 Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
DE69602208T Revoked DE69602208T2 (de) 1995-10-27 1996-10-25 Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69602208T Revoked DE69602208T2 (de) 1995-10-27 1996-10-25 Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine

Country Status (11)

Country Link
US (1) US6017966A (de)
EP (1) EP0859635B1 (de)
JP (1) JPH11504344A (de)
AT (1) ATE179075T1 (de)
AU (1) AU7308296A (de)
CA (1) CA2232419A1 (de)
DE (2) DE859635T1 (de)
ES (1) ES2132964T3 (de)
FR (1) FR2740337B1 (de)
GR (1) GR3030026T3 (de)
WO (1) WO1997015329A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756758C1 (de) * 1997-12-19 1999-08-05 Solvay Pharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Dopamin oder Dobutamin
CN112444497A (zh) * 2020-10-23 2021-03-05 马鞍山丰原制药有限公司 一种盐酸多巴酚丁胺含量的检测方法
CN114617844A (zh) * 2022-04-20 2022-06-14 江苏吴中医药集团有限公司 一种盐酸多巴酚丁胺水针注射液的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3808317A (en) * 1969-10-29 1974-04-30 Alcon Labor Inc Stabilized aqueous borate complexes of biologically active catechol amines
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
FR2231377B1 (de) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
RO93391B (ro) * 1984-12-20 1988-03-31 Eli Lilly And Company Procedeu pentru prepararea unor saruri de dobutamina
US4980159A (en) * 1989-05-23 1990-12-25 Bristol-Myers Squibb Company Processes and compositions for the topical application of β-adrenergic agonists for pilomotor effects
AU5680994A (en) * 1992-12-10 1994-07-04 Abbott Laboratories Stabilized catecholamine solutions

Also Published As

Publication number Publication date
DE69602208D1 (de) 1999-05-27
FR2740337A1 (fr) 1997-04-30
WO1997015329A1 (fr) 1997-05-01
ATE179075T1 (de) 1999-05-15
AU7308296A (en) 1997-05-15
ES2132964T3 (es) 1999-08-16
US6017966A (en) 2000-01-25
CA2232419A1 (fr) 1997-05-01
FR2740337B1 (fr) 1997-11-21
JPH11504344A (ja) 1999-04-20
GR3030026T3 (en) 1999-07-30
EP0859635B1 (de) 1999-04-21
EP0859635A1 (de) 1998-08-26
DE69602208T2 (de) 1999-09-02

Similar Documents

Publication Publication Date Title
MX9202247A (es) Composiciones de globulos recubiertos con medicamentos de baja solubilidad.
DE69001730T2 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
FR2696094B1 (fr) Nouvelles compositions pharmaceutiques contenant des cyclosporines.
BR9611096B1 (pt) composição farmacêutica compreendendo um extrato estável de hypericum perforatum l.
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
NO954320L (no) Lyosfærer omfattende gonadotropin
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
DE69006094T2 (de) Pharmazeutische Zusammensetzungen.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
DE68918847T2 (de) Stabile pharmazeutische zusammensetzung.
DE69720269D1 (de) Gelierungsstabiele polyhalogenphosphazenverbindungen
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
DE69602208D1 (de) Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
DE69017969T2 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
ATE201996T1 (de) Hirudin enthaltende pharmazeutische zusammensetzungen
IT8722855A0 (it) Composizione insetticida.
ATE171863T1 (de) Dermato-kosmetologisches präparat
ATE211383T1 (de) Topische aciclovir-zubereitung
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
BG102904A (en) 1,4-diaryl-2,3-difluoro-2-butene insecticide and acaricidal forms